Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Semiconductor manufacture Spray-dried-vitamin-E-powder

 Process for the production of a sensitive plate for an exoelectron dosimeter
The present invention relates to a process for carrying out the deposition of the mixture of the ...


 Working up of the residual gases resulting from the production of cyanuric chloride
What is claimed is: 1. A process for working up the chlorine containing residual gases obtained in ...


 Aqueous coating composition from a mercaptan containing polymer and a bis-maleimide
OF THE INVENTION The coating composition contains a polymer or resin selected according to final ...


 Erasable ball-point pen ink
OF THE INVENTION The excellent writing performance described hereinbefore and hereinafter implies ...


 Automatic enzyme immunoassay apparatus
It is therefore an object of the present invention to provide an automatic enzyme immunoassay ...


 Gas sensor
In accordance with the present invention, an electrochemical gas sensor for sensing an alkaline gas ...


 Photometer-digitizer system
In a preferred embodiment of the present invention a two-dimensional vidicon photometer having ...


 Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension
Among the objects of the invention, therefore, may be noted the provision of a method for the ...


 Rapid and sensitive detection of herpes simplex virus
OF THE INVENTION 5.1 Definitions By the terms "enzymatically amplify" or "amplify" is meant, for ...


 Film strip for rapid test of a film processor
OF THE INVENTION FIG. 1 is a layout view of a film test strip in accordance with the present ...


 Spray dried vitamin E powder

Details
Inventors: Schmidt, Douglass N.; Fischetti, Jr., Frank;
Assignee: BASF Wyandotte Corporation (Wyandotte, MI)
Primary Examiner: Roberts; Elbert L.
Assistant Examiner:
Attorney, Agent or Firm: Pierce; Andrew E.

Spray dried vitamin E powders comprising 50 to 56 percent by weight vitamin E, 1 to 25 percent by weight hydrolyzed gelatin and 20 to 30 percent by weight caseinate. The resulting powders can be directly compressed into tablets of improved hardness and friability.

DETAILED DESCRIPTION The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1.
A vitamin E powder suitable for the preparation of direct compression vitamin tablets comprising 20 to 60 percent by weight Vitamin E, 0.
5 to 2.
0 percent by weight silicon dioxide having a particle size of 1 millimicron to 1 micron, 1 to 25 percent by weight hydrolyzed gelatin, and about 20 to 30 percent by weight caseinate, with the proviso that the weight ratio of caseinate to gelatin be greater than 1:1 all weight based on the total weight of powder.
2.
A vitamin E powder suitable for the preparation of direct compression vitamin tablets consisting essentially of 50 percent by weight to 56 percent by weight of vitamin E, 0.
5 percent by weight to 2.
0 percent by weight of silicon dioxide having a particle size of 1 millimicron to 1 micron, 1 percent by weight to 25 percent by weight of a hydrolyzed gelatin, about 20 percent by weight to about 30 percent by weight of a caseinate and the remainder to 100 percent by weight of a monoglyceride and/or a tabletting excipient, with the proviso that the weight ratio of caseinate to gelatin be greater than 1:1, all weights based on the total weight of powder.
3.
The powder of claim 2 wherein the vitamin E is vitamin E acetate.
4.
The powder of claim 2 wherein the tabletting excipient is lactose.
5.
The powder of claim 2 containing from 1.
0 to 1.
5 percent by weight monoglyceride.
6.
A vitamin E acetate powder suitable for the preparation of direct compression vitamin tablets comprising 50 percent by weight to 56 percent by weight vitamin E acetate, 1.
0 percent by weight to 2.
0 percent by weight silicon dioxide having a particle size of 1 millimicron to 1 micron, 1.
0 percent by weight to 1.
5 percent by weight distilled monoglyceride, 0 percent by weight to 22 percent by weight lactose, 10 percent by weight to 22 percent by weight hydrolyzed gelatin, and 20 percent by weight to 27 percent by weight caseinate, with the proviso that the weight ratio of caseinate to gelatin be greater than 1:1, all weights based on the total weight of powder



Related patents
  Dry stabilized microemulsified omega-three acid-containing oils
The marine animal oil to be microemulsified may be derived from any desired marine animal source. Among the marine animal oils particularly contemplated for use are ...
  Anti-ulcer composition
OF THE INVENTION The present invention provides an improved composition for ulcer curative/ulcer therapy agents capable of forming an ulcer-adherent protective complex, ...
  Pediatric effervescent dosage form
OF THE PREFERRED EMBODIMENT An oral dosage form according to one embodiment of the present invention is a tablet of a size and shape adapted for direct oral ...
  Defoaming composition
OF THE INVENTION The preferred fluid, nonaqueous, antifoaming or defoaming compound prepared as a flowable granule used herein is simethicone and, more specifically, ...
  Fire-resistant styrene polymer foams
OF THE INVENTION In accordance with the invention, a variety of expandable thermoplastic homopolymers and copolymers can be made to have reduced flammability. The ...
  Tissue processing method
I claim: 1. A method of processing a tissue specimen, comprising the steps of suspending the specimen in condensing vapours of a volatile dehydrating agent, condensing ...
  Flame retardant compositions derived from difunctional carboxylic acids containing a halogenated thiophere ring and methods for their preparation
OF THE INVENTION The flame-retardant polyesters of this invention are derived, at least in part, from mono- or dihalogenated thiophene dicarboxylic acids. The ...
  Radioactive scanning agents with stabilizer
OF THE INVENTION This invention is based on the discovery that gentisyl alcohol and its phenolate salts and esters (all hereinafter "gentisols") can be utilized to ...
  Homocysteine thiolactone perchlorate as a tumor promotor
I claim: 1. A method of promoting the growth of malignant tumors in laboratory animals such as mice and rabbits which comprises utilizing intraperitoneally an effective ...
  Time-release
We claim: 1. A tablet or dragee core for a time-release pharmaceutical composition, suitable for oral administration, which comprises as active ingredient 50 to 70% by ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved